Study: Treatment ineffective for newborns with low oxygen or blood supply
Erythropoietin, a treatment for newborns with critically low levels of oxygen or blood supply to the brain at birth, does not prevent death or disability, according to a new multinational study. The research will be presented at the Pediatric Academic Societies (PAS) 2025 Meeting, held April 24-28 in Honolulu.
Researchers found that a high-dose treatment with erythropoietin, paired with standard cooling treatments, does not reduce death, rate of cerebral palsy, or physical or cognitive impairment ...